logo
Editorial: Are there new approaches to roll back trypanosomiasis?
The situation of sleeping sickness in Angola: a calamity
Sleeping sickness resurgence in the DRC: the past decade
Re-emergence of epidemic sleeping sickness in southern Sudan
Sleeping sickness surveillance: an essential step towards elimination
The story of CGP 40 215: studies on its efficacy and pharmacokinetics in African green monkey infected with Trypanosoma brucei rhodesiense
Evaluation of quinolone derivatives for antitrypanosomal activity
Clinical description of encephalopathic syndromes and risk factors for their occurrence and outcome during melarsoprol treatment of human African trypanosomiasis
Molecular characterization of field isolates of human pathogenic trypanosomes
Melarsoprol refractory T. b. gambiense from Omugo, north-western Uganda
Pharmacokinetic investigations in patients from northern Angola refractory to melarsoprol treatment